Consensus-based care recommendations for adults with myotonic dystrophy type 1

Archive ouverte

Ashizawa, Tetsuo | Gagnon, Cynthia | Groh, William | Gutmann, Laurie | Johnson, Nicholas | Meola, Giovanni | Moxley, Richard | Pandya, Shree | Rogers, Mark | Simpson, Ericka | Angeard, Nathalie | Bassez, Guillaume | Berggren, Kiera | Bhakta, Deepak | Bozzali, Marco | Broderick, Ann | Byrne, Janice L.B. | Campbell, Craig | Cup, Edith | Day, John | de Mattia, Elisa | Duboc, Denis | Duong, Tina | Eichinger, Katy | Ekstrom, Anne-Berit | van Engelen, Baziel | Esparis, Belen | Eymard, Bruno | Ferschl, Marla | Gadalla, Shahinaz | Gallais, Benjamin | Goodglick, Todd | Heatwole, Chad | Hilbert, James | Holland, Venessa | Kierkegaard, Marie | Koopman, Wilma | Lane, Kari | Maas, Daphne | Mankodi, Ami | Mathews, Katherine | Monckton, Darren | Moser, David | Nazarian, Saman | Nguyen, Linda | Nopoulos, Peg | Petty, Richard | Phetteplace, Janel | Puymirat, Jack | Raman, Subha | Richer, Louis | Roma, Elisabetta | Sampson, Jacinda | Sansone, Valeria | Schoser, Benedikt | Sterling, Laurie | Statland, Jeffrey | Subramony, S.H. | Tian, Cuixia | Trujillo, Careniña | Tomaselli, Gordon | Turner, Chris | Venance, Shannon | Verma, Aparajitha | White, Molly | Winblad, Stefan

Edité par CCSD ; The American Academy of Neurology -

International audience. Purpose of review Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic disease that affects between 1 in 3,000 and 8,000 individuals globally. No evidence-based guideline exists to inform the care of these patients, and most do not have access to multidisciplinary care centers staffed by experienced professionals, creating a clinical care deficit. Recent findings The Myotonic Dystrophy Foundation (MDF) recruited 66 international clinicians experienced in DM1 patient care to develop consensus-based care recommendations. MDF created a 2-step methodology for the project using elements of the Single Text Procedure and the Nominal Group Technique. The process generated a 4-page Quick Reference Guide and a comprehensive, 55-page document that provides clinical care recommendations for 19 discrete body systems and/or care considerations. Summary The resulting recommendations are intended to help standardize and elevate care for this patient population and reduce variability in clinical trial and study environments.

Consulter en ligne

Suggestions

Du même auteur

Consensus-based care recommendations for adults with myotonic dystrophy type 2

Archive ouverte | Schoser, Benedikt | CCSD

International audience. Purpose of review Myotonic dystrophy type 2 (DM2) is a rare, progressive multisystem disease particularly affecting the skeletal muscle. A causal therapy is not yet available; however, prompt...

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

Archive ouverte | Okkersen, Kees | CCSD

International audience

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Archive ouverte | Flower, Michael | CCSD

International audience. Abstract The mismatch repair gene MSH3 has been implicated as a genetic modifier of the CAG·CTG repeat expansion disorders Huntington’s disease and myotonic dystrophy type 1. A recent Hunting...

Chargement des enrichissements...